HX111

· Hanx Biopharmaceuticals (Wuhan) Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HX111, covering 2026-01-13 to 2026-01-13. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Study of HX111 in Patients With Advanced Solid Tumor and Lymphoma [Phase 1, Phase 2]